Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
Complaint Counsel's Post Trial Brief - Federal Trade Commission
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
276. Duke does not thnk of black cohosh as a major anticancer herb. (R18 (Duke, Dep. at<br />
123)).<br />
277. Duke stated that there is no reference to cancer in eleuthero because "that's not one ofthe<br />
major things that are said about it." (R18 (Duke, Dep. at 125-26)).<br />
278. Most ofthe studies Duke has seen have been for preventing cancer. (R18 (Duke, Dep. at<br />
128)).<br />
279. Duke does not remember any studies specifically about treating cancer. (R18 (Duke,<br />
Dep. at 128-29)).<br />
280. Duke testified that anecdotal reports are "even below. . . my lines of evidence." (R18<br />
(Duke, Dep. at 131)).<br />
281. Duke attbutes the increase in life expectancy in the 150 years that pharaceuticals have<br />
been around to pharaceuticals themselves. (R18 (Duke, Dep. at 133)).<br />
282. Duke does not believe that homeostatic balancing has been the subject of any peerreviewed<br />
aricles in connection with the treatment or cure of cancer. (R18 (Duke, Dep. at<br />
133-34).<br />
283. In Duke's IE, there have been no clinical trals as to the effcacy of black cohosh for<br />
cancer. (R18 (Duke, Dep. at 147)).<br />
284. There are no clinical trals regarding garlic's effcacy as to cancer in Duke's IE. (R18<br />
(Duke, Dep. at 148)).<br />
285. There are no clinical trals regarding Yellow Root's effcacy as to cancer in Duke's IE.<br />
(R18 (Duke, Dep. at 149)).<br />
286. There are no clincal trals regarding eleuthero's effcacy<br />
(Duke, Dep. at 153)).<br />
as to cancer in Duke's IE. (R18<br />
287. There are no clinical trals regarding soybean's effcacy as to cancer in Duke's IE. (R18<br />
(Duke, Dep. at 153-54)).<br />
288. There are no entres for sarsaparlla in Duke's IE indicating that it has been evaluated for<br />
its effcacy in treating cancer in clincal trals. (R18 (Duke, Dep. at 156)).<br />
289. The editors of<br />
Duke's book, The Green Pharacy Guide to Healing Foods, advised Duke<br />
to "shy away from" a section on cancer treatment. (R18 (Duke, Dep. at 178)).<br />
290. Duke does not recall seeing any arcles that Mr. and Mrs. Feijo believe substantiated the<br />
claims that they made regarding the paricular DCO Products. (R18 (Duke, Dep. at<br />
185)).<br />
291. Duke has made no effort to evaluate whether the combination of the ingredients in each<br />
ofthe products that DCO sells - GDU, 7 Herb Formula, and BioMixx - has any<br />
synergistic effects. (R18 (Duke, Dep. at 190); Duke, Tr. 525-26).<br />
27
Change language